Tumbling to a price of $16.73 during today's evening trading session, shares of Sotera Health Company are now -16.35% below their average target price of $20.0. Does this mean the stock will reverse course? Analysts are giving SHC an average rating of buy and target prices ranging from 18.0 to 24.0 dollars per share.
The market seems to share this rosy outlook, since Sotera Health Company has a short interest of only 4.7%. This represents the percentage of the share float that is being shorted, and each short position stands for an investor's expectation that the price of the stock will go down in the future.
When a stock is sold short, it means an investor has borrowed shares of the stock from their broker, and then sold them at the going market price. The investor hopes for the price to decline, so that they might buy those shares back at a lower price in the future. Once they do, they can return the borrowed shares to their broker, and keep the profit they made on the transaction.
One way to get an idea of the market sentiment on a stock is to check its rate of institutional ownership. In the case of Sotera Health Company, institutional investors own 88.9% of the shares, which indicates they have a very high stake in the company. What does this really tell us?
Institutional investors such as hedge funds, investment firms, and wealth managers devote significant resources to identifying good investments. If they have decided to invest in SHC, it probably means they believe it is a solid investment choice.
But it could also mean they are buying up shares in an effort to acquire the company or to get seats on the board of directors. Also bear in mind that institutions are fallible (just maybe not quite as fallible as the average retail investor), so they may simply be wrong when they think they've found a good stock.
To sum up, Sotera Health Company is probably the subject of mixed market sentiment because of an analyst consensus of some upside potential, a buy rating, an average amount of shares sold short, and a significant number of institutional investors. At Market Inference, we believe that any investment decision should be preceded by an in-depth analysis of the company's fundamental values and a comparison with similar stocks.
Here's a snapshot of some important facts to keep in mind about SHC:
The stock has trailing 12 month earnings per share (EPS) of $-0.81
Sotera Health Company has a trailing 12 month Price to Earnings (P/E) ratio of -20.7 compared to the S&P 500 average of 15.97
The company has a Price to Book (P/B) ratio of 13.5 in contrast to the S&P 500's average ratio of 2.95
Sotera Health Company is a Health Care company, and the sector average P/E and P/B ratios are 24.45 and 4.16 respectively